Cooper Companies Director Kurzius Buys $549,300 in Shares. Is the Eye Care Stock About to Rally?
2026-10-02 17:11
•Brendan Coffey •The Motley Fool
• ••• Axe Cap view
Insider Buying in Cooper Companies Signals Potential Turnaround
Director Kurzius's sizeable share purchase suggests management's confidence in Cooper's recovery.
A company director buying a substantial chunk of shares always catches the eye. Lawrence Kurzius just added over half a million dollars worth of Cooper Companies stock after the share price fell 16% in the past year. This isn’t small change and typically signals that those closest to the company think it’s undervalued. Cooper’s decision to keep its surgical division shows they believe in future growth rather than short-term gains. For South African investors, it’s a reminder to watch USD/ZAR closely since Cooper reports in dollars and a weaker rand would add some currency risk. If the dollar strengthens sharply, any gains in Cooper might get eroded locally. While this insider buy is encouraging, sluggish global economic growth or unexpected competition in medical devices could spoil the rally. this is just our opinion and not financial advice
Watch Cooper Companies for a potential buy on any price dips, but hedge currency exposure via USD/ZAR. Avoid chasing up moves until the rand-dollar dynamic settles.
- USD/ZAR
- COO
- US dollar strength hurting rand-based returns
- global healthcare demand slowing unexpectedly
5/10
Lawrence Erik Kurzius, a Director at Cooper Companies, purchased 10,000 shares worth $549,300 at $54.93 per share on September 16, 2026, increasing his total holdings to 31,099 shares. The insider buy signals confidence in the company's recovery prospects following a 16% stock decline over the past year. The article notes that insider purchases typically predict higher share prices within 30 days and suggest management believes in the company's long-term growth, particularly after deciding to retain its surgical unit rather than divest it.
Our take is based on reporting first published by The Motley Fool.